Hyperthermia, one of the oldest forms of cancer treatment involves selective heating of tumor
tissues to temperatures ranging between 39 and 45° C. Recent developments based on the …

Clinically established thermal therapies such as thermoablative approaches or adjuvant
hyperthermia treatment rely on accurate thermal dose information for the evaluation and …

CEM43 has its roots in the direct cytotoxic effect of heat, whereby the amount of cell death
depends on the temperature and exposure time. CEM43 is a normalising method to convert …

Clinical trials have shown that hyperthermia (HT), ie an increase of tissue temperature to 39–
44° C, significantly enhance radiotherapy and chemotherapy effectiveness [1]. Driven by the …

Hyperthermia therapy is a potent enhancer of chemotherapy and radiotherapy. In particular,
microwave (MW) and radiofrequency (RF) hyperthermia devices provide a variety of heating …

Hyperthermia therapy (HT) raises tissue temperature to 40–45° C for up to 60 min.
Hyperthermia is one of the most potent sensitizers of radiation therapy (RT). Ultrasound …

Moderate hyperthermia at temperatures between 40 and 44° C is a multifaceted therapeutic
modality. It is a potent radiosensitizer, interacts favorably with a host of chemotherapeutic …

Introduction Hyperthermia therapy (HT) is a recognized treatment modality, that can
sensitize tumors to the effects of radiotherapy (RT) and chemotherapy by heating up tumor …

Thermal ablation techniques such as radiofrequency, microwave, high intensity focused
ultrasound (HIFU) and laser have been used as minimally invasive strategies for the …

These guidelines were developed by the Atzelsberg Research Group of the IAH (http://www.
hyperthermie. org) of the German Cancer Society (“Deutsche Krebs gesellschaft”) to …